Dr. Reddy’s drug discovery operations at Hyderabad will be absorbed into Aurigene, a wholly owned subsidiary of the company, effective July 1, 2009. As part of the reorganization, the company will close its Atlanta research facility in the U.S. Aurigene is a partnership based drug discovery biotechnology company headquartered in Bangalore, India. The discovery research resources, employees, facility and infrastructure, will transition into Aurigene, which will now operate from two sites in Ba...